trending Market Intelligence /marketintelligence/en/news-insights/trending/bRvZTzhfuG1ifPnDrGz-_A2 content esgSubNav
In This List

Akorn passes US FDA reinspection of facility in Decatur, Illinois

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Akorn passes US FDA reinspection of facility in Decatur, Illinois

The U.S. FDA completed its reinspection of Akorn Inc.'s facility in Decatur, Ill.

The reinspection is a follow-up to verify the implementation and effectiveness of Akorn's responses to the FDA's observations from a June inspection of the facility, which constituted six violations of the Food Drug and Cosmetic Act.